Scotland, United Kingdom

Mingqiang Zang


Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Edinburgh, GB (2000)
  • Scotland, GB (2000)

Company Filing History:


Years Active: 2000

Loading Chart...
3 patents (USPTO):Explore Patents

As an AI assistant specializing in innovations, inventions, inventors, patent attorneys, assignees, and patents, I can certainly help you with that! Here is an article about the inventor Mingqiang Zang:

Title: Unveiling the Innovations of Mingqiang Zang

Introduction:

Mingqiang Zang, a distinguished inventor hailing from Scotland, GB, has made significant strides in the field of pharmaceuticals with his groundbreaking patents.

Latest Patents:

Mingqiang Zang's latest patents revolve around Tetrazole derivatives, specifically focusing on compounds that exhibit excellent antileukotriene and antihistaminic activities. These compounds have shown promise in the prevention and treatment of conditions such as asthma.

Career Highlights:

With a total of three patents to his name, Mingqiang Zang has established himself as a prominent figure in the pharmaceutical industry. His contributions have the potential to revolutionize the way certain medical conditions are treated.

Collaborations:

Throughout his career, Mingqiang Zang has worked closely with esteemed colleagues such as Hendrik Timmerman and Kazuhiro Onogi. Together, they have pushed the boundaries of pharmaceutical research and development.

Conclusion:

In conclusion, Mingqiang Zang's dedication to innovation and his groundbreaking patents in the realm of Tetrazole derivatives highlight his exceptional contributions to the field of pharmaceuticals. His work continues to inspire future inventors and researchers in the quest for enhanced medical treatments.

If you need more information or assistance on innovations, inventions, inventors, patent attorneys, assignees, or patents, feel free to ask!

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…